2022
Widespread sharing of pneumococcal strains in a rural African setting: proximate villages are more likely to share similar strains that are carried at multiple timepoints
Senghore M, Chaguza C, Bojang E, Tientcheu P, Bancroft R, Lo S, Gladstone R, McGee L, Worwui A, Foster-Nyarko E, Ceesay F, Okoi C, Klugman K, Breiman R, Bentley S, Adegbola R, Antonio M, Hanage W, Kwambana-Adams B. Widespread sharing of pneumococcal strains in a rural African setting: proximate villages are more likely to share similar strains that are carried at multiple timepoints. Microbial Genomics 2022, 8: 000732. PMID: 35119356, PMCID: PMC8942022, DOI: 10.1099/mgen.0.000732.Peer-Reviewed Original ResearchConceptsTransmission dynamicsRural African settingLogistic regression modelsPCV7 serotypesLongitudinal cohortCarriage episodesUnique serotypesPneumococcal strainsInfantsPairwise SNP distanceMultiple timepointsAfrican settingSNP distanceSustained colonizationRegression modelsSaharan AfricaCarriageSerotypesRural AfricaIntra-strain diversityPneumococcal genomeNeighbouring villagesCohort
2020
Using genomics to improve preparedness and response of future epidemics or pandemics in Africa
Chaguza C, Nyaga MM, Mwenda JM, Esona MD, Jere KC. Using genomics to improve preparedness and response of future epidemics or pandemics in Africa. The Lancet Microbe 2020, 1: e275-e276. PMID: 33345202, PMCID: PMC7729821, DOI: 10.1016/s2666-5247(20)30169-5.Peer-Reviewed Original Research
2017
The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1
Cornick JE, Bishop Ö, Yalcin F, Kiran AM, Kumwenda B, Chaguza C, Govindpershad S, Ousmane S, Senghore M, du Plessis M, Pluschke G, Ebruke C, McGee L, Sigaùque B, Collard JM, Bentley SD, Kadioglu A, Antonio M, von Gottberg A, French N, Klugman KP, Heyderman RS, Alderson M, Everett DB, consortium F. The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1. Vaccine 2017, 35: 972-980. PMID: 28081968, PMCID: PMC5287219, DOI: 10.1016/j.vaccine.2016.12.037.Peer-Reviewed Original ResearchConceptsProtein vaccine candidatePneumococcal protein vaccinesProtein vaccineVaccine candidatesSerotype 1Multi-valent vaccinesSerotype 1 pneumococciPneumococcal conjugate vaccineHuman immune responseImportant pneumococcal serotypesConjugate vaccinePneumococcal diseasePneumococcal serotypesVaccine interventionsCommon causeImmune responseStudy populationAllelic variantsTarget antigenVaccineS. pneumoniae TIGR4Pneumococcal populationIntervention strategiesPCPADifferent allelic variants
2016
Understanding pneumococcal serotype 1 biology through population genomic analysis
Chaguza C, Cornick JE, Harris SR, Andam CP, Bricio-Moreno L, Yang M, Yalcin F, Ousmane S, Govindpersad S, Senghore M, Ebruke C, Du Plessis M, Kiran AM, Pluschke G, Sigauque B, McGee L, Klugman KP, Turner P, Corander J, Parkhill J, Collard JM, Antonio M, von Gottberg A, Heyderman RS, French N, Kadioglu A, Hanage WP, Everett DB, Bentley SD, for the PAGe Consortium. Understanding pneumococcal serotype 1 biology through population genomic analysis. BMC Infectious Diseases 2016, 16: 649. PMID: 27821148, PMCID: PMC5100261, DOI: 10.1186/s12879-016-1987-z.Peer-Reviewed Original ResearchConceptsDisease burdenPneumococcal disease burdenSerotype 1 pneumococciSub-Saharan AfricaHigh prevalenceHuman nasopharynxAfrican isolatesLow-income countriesSerotype 1Longer durationFurther studiesTetracycline resistanceBiological mechanismsST217West African isolatesDifferent geographical regionsSuccessful clones